Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers

[1]  J. Kulka,et al.  Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions , 2015, Pathobiology.

[2]  H. Gobbi,et al.  Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast , 2014, Diagnostic Pathology.

[3]  S. Jaffer,et al.  Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma , 2014, Modern Pathology.

[4]  G. Cserni.  Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells—potential pitfalls in diagnosing malignancy , 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[5]  S. Schnitt,et al.  Phenotypic Alterations in Myoepithelial Cells Associated With Benign Sclerosing Lesions of the Breast , 2010, The American journal of surgical pathology.

[6]  T. Yankeelov,et al.  NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  S. Schnitt,et al.  Phenotypic Alterations in Ductal Carcinoma In Situ-associated Myoepithelial Cells: Biologic and Diagnostic Implications , 2009, The American journal of surgical pathology.

[8]  G. Cserni.  Presence of Basement Membrane Material around the Tubules of Tubulolobular Carcinoma , 2008, Breast Care.

[9]  S. Bianchi,et al.  Microinvasive Carcinoma of the Breast , 2008, Pathology & Oncology Research.

[10]  I. Ellis,et al.  The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal , 2006, Journal of Clinical Pathology.

[11]  I. Ellis,et al.  Impact of a national external quality assessment scheme for breast pathology in the UK , 2006, Journal of Clinical Pathology.

[12]  J. Fleiss,et al.  The measurement of interrater agreement , 2004 .

[13]  I. Ellis,et al.  Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. , 2002, Human pathology.

[14]  A. Gown,et al.  Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast , 1999, Virchows Archiv.

[15]  U. Sauer,et al.  Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer. , 1997, Anticancer research.

[16]  A. Cassoni.  Tnm Classification of Malignant Tumours , 1987 .

[17]  B. Gusterson,et al.  Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. , 1982, Cancer research.

[18]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[19]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[20]  A. Valachis,et al.  Sentinel lymph node biopsy in patients with microinvasive breast cancer: a systematic review and meta-analysis. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  A. Corben,et al.  Sentinel lymph node biopsy in patients with microinvasive breast cancer: A systematic review and meta-analysis: Gojon H, Fawunmi D, Valachis A (Karolinska Solna, Stockholm, Sweden; Mälarsjukhuset, Eskilstuna, Sweden) Eur J Surg Oncol 40:5-11, 2014§ , 2014 .

[22]  Consumer Protection,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.